Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
3.7200
0.0000
(0.00%)
As of February 24 at 8:06:54 AM GMT+1. Market Open.
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Thomas J. Schaefer C.F.A. | CEO, President & Director | 341.68k | -- | 1977 |
| Mr. Mark Kawakami | Chief Financial Officer | -- | -- | -- |
Arcadia Biosciences, Inc.
- Sector:
- Consumer Defensive
- Industry: Packaged Foods
- Full Time Employees:
- 21
Description
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
Corporate Governance
Arcadia Biosciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 26, 2025 at 10:59 AM UTC - March 31, 2025 at 12:00 PM UTC
Arcadia Biosciences, Inc. Earnings Date
Recent Events
Recent Events Information Not Available